Advertisement.

SCPS Projected Dividend Yield

Scopus BioPharma Inc ( OTCBB : SCPS )

Scopus BioPharma is a biopharmaceutical company developing therapeutics for serious diseases. Co. is focusing on its immuno-oncology programs, which are conducted primarily through Duet BioTherapeutics Inc. (Duet), its majority-owned subsidiary. The Duet Platform is comprised of three complementary bifunctional oligonucleotides that each consist of a toll-like receptor 9 agonist (i.e., CpG ODN) linked with a signal transducer and activator of transcription 3 inhibitor: RNA silencing - CpG-STAT3siRNA (DUET-01); Antisense - CpG-STAT3ASO (DUET-02); and DNA-binding inhibitor - CpG-STAT3decoy (DUET-03).

21 YEAR PERFORMANCE RESULTS

SCPS Dividend History Detail
SCPS Dividend News
SCPS Competitors News

# of Shares: 0

Closing Price: 0.00

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000